Industry Therapeutic Update From Sanofi Medical at the 2024 AAN Annual Meeting

Non-Relapsing SPMS: Perspectives From a Person Living with MS and a Review of the Underlying CNS Biology

Despite current treatment options, disability accumulation remains a reality for many people living with MS, including those with non-relapsing SPMS. In this exciting session, we heard from a person living with SPMS through a candid conversation with a physician about their MS journey. In addition, an MS expert addressed the underlying biology of SPMS and how changes in the CNS immune microenvironment are thought to drive non-relapsing biology. BTK within disease-associated microglia in particular, was presented as a potential target for future therapies to slow disability accumulation across the spectrum of MS.


ITU FROM SANOFI MEDICAL

SPEAKER BIOGRAPHIES

*This program is non-promotional, is sponsored by Sanofi Medical, and the content contained in this presentation was developed by Sanofi Medical in collaboration with the speakers. The speakers were compensated by Sanofi in connection with this presentation. This presentation is not eligible for CME.